A study of the impact of the 21‐gene breast cancer assay on the use of adjuvant chemotherapy in women with breast cancer in a Mexican public hospital

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|111|2|203-207

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.2, 2015-02, pp. : 203-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of the Onco type DX™ 21-Gene Assay to Guide Adjuvant Decision Making in Early-Stage Breast Cancer

By Conlin Alison K.   Seidman Andrew D.  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 6, 2007-01 ,pp. : 355-360

Adis International

Access to resources Recommend Favorite

Population‐based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years

By  

CANCER, Vol. 121, Iss. 22, 2015-11 ,pp. : 4062-4070

John Wiley & Sons Inc

Access to resources Recommend Favorite

Taxanes in adjuvant chemotherapy for early breast cancer

By Vincenzi Bruno   Santini Daniele   Tonini Giuseppe  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 323-325

Future Medicine

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Breast Cancer: Back to the Future

By  

Oncology Research and Treatment, Vol. 26, Iss. 2, 2003-05 ,pp. : 111-112

Karger

Access to resources Recommend Favorite

Risk-Adapted Chemotherapy in the Adjuvant Setting of Breast Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-07 ,pp. : 200-201

Karger

Access to resources Recommend Favorite